Investor Presentation

RNS Number : 3486A

Omega Diagnostics Group PLC

29 September 2020

 

Omega Diagnostics Group plc

("Omega" or "the Group" or "the Company")

Investor Presentation

Omega Diagnostics Group plc (AIM: ODX), the medical diagnostics company focused on CD4, infectious diseases and food intolerance, announces that Colin King, Chief Executive, will be presenting at an investor webinar being hosted jointly by Turner Pope Investments (TPI) Ltd and Vox Markets.

The event will be held on Monday, 5 October 2020 at 2pm. To access the event, please register your interest at https://voxmarkets.brand.live/c/omega-diagnostics-investor-presentation

No new price-sensitive information is disclosed as part of the presentation. Within the presentation the Company provides indicative guidance on timelines for product evaluations, product supply, potential timing for first commercial sales and targeted production volumes. These timelines are for guidance purposes only and there is no guarantee that these will be met. The Company expects to keep shareholders updated regularly on progress in achieving these future milestones.

For further information, please contact:

Omega Diagnostics Group PLC		Tel: [phone]
Colin King, Chief Executive		www.omegadiagnostics.com
Kieron Harbinson, Group Finance Director
finnCap Ltd		Tel: [phone]
Geoff Nash / Teddy Whiley (Corporate Finance)
Alice Lane (ECM)
Walbrook PR Limited	Tel: [phone] or  [e-mail]
Paul McManus		Mob: [phone]
Lianne Cawthorne		Mob: [phone]

 

END

 

 

NRAUWSVRRVUKUAR